Resunab for the Treatment of Lupus: What to Know About it

Wendy Henderson avatar

by Wendy Henderson |

Share this article:

Share article via email

In this short video from Corbus Pharmaceutical Holdings Ltd, Dr. Meggan Mackay from the Hofstra Northwell School of Medicine, Hempstead, New York, tells us a little bit about Resunab treatment for lupus.

Read how Corbus added a clinical protocol to a lupus Phase 2 trial for Resunab.

Dr. Mackay talks briefly about a study funded by the National Institute for Health in co-operation with Corbus Pharmaceutical Holdings Ltd and the Autoimmune Centers of Excellence where lupus patients will be treated with Resunab.

Find out about 23andMe’s genetic research into lupus.

Lupus News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Print This Page

About the Author

Wendy Henderson avatar
Wendy Henderson Wendy is a proven blogger and social media manager who has helped to build online communities for businesses and organizations. She currently heads the website’s social outreach online through social media platforms such as Facebook, Twitter, and Pinterest.

Tags

Autoimmune Centers of Excellence, Corbus Pharmaceuticals Holdings, NIH, resunab, resunab treatment

Recent Posts


Recommended reading